Correlation Between Aerovate Therapeutics and Kainos Group

Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Kainos Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Kainos Group into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aerovate Therapeutics and Kainos Group plc, you can compare the effects of market volatilities on Aerovate Therapeutics and Kainos Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Kainos Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Kainos Group.

Diversification Opportunities for Aerovate Therapeutics and Kainos Group

-0.66

Correlation Coefficient

Aerovate Therapeutics  Kainos Group

Excellent diversification

The 3 months correlation between Aerovate and Kainos is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Kainos Group plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kainos Group plc and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Kainos Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kainos Group plc has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Kainos Group go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and Kainos Group

Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the Kainos Group. But the stock apears to be less risky and, when comparing its historical volatility, Aerovate Therapeutics is 1.08 times less risky than Kainos Group. The stock trades about 0.0 of its potential returns per unit of risk. The Kainos Group plc is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  2,443  in Kainos Group plc on September 19, 2024 and sell it today you would lose (1,372) from holding Kainos Group plc or give up 56.16% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	99.8%
Values	Daily Returns

Aerovate Therapeutics  vs.  Kainos Group plc

Aerovate Therapeutics

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Kainos Group plc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Kainos Group plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Aerovate Therapeutics and Kainos Group

The main advantage of trading using opposite Aerovate Therapeutics and Kainos Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Kainos Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kainos Group will offset losses from the drop in Kainos Group's long position.

The idea behind Aerovate Therapeutics and Kainos Group plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.